The varicose vein treatment market in North America and Europe is projected to reach to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, growing at a CAGR of 6.9% from 2016 to 2021.

Objectives of the study are:

To define, describe, and forecast the varicose vein treatment market in North America and Europe on the basis of mode of treatment, products, and regions
To provide detailed information regarding major factors influencing the growth of the varicose vein treatment market in North America and Europe (drivers, restraints, opportunities, and industry-specific challenges)
To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
To strategically profile the key players and comprehensively analyze their market shares
To estimate and forecast the varicose vein treatment market by mode and product in North America (U.S. and Canada) and Europe (Germany, U.K., France, Italy, Spain, and Rest of Europe)


Research Methodology

This research study involved the extensive use of secondary sources, directories, and databases (such as Hoovers, Bloomberg Business, Factiva, and Avention) to identify and collect information useful for this technology-based, market-oriented, and commercial study of the North America and Europe varicose vein treatment market. In-depth interviews were conducted with various primary respondents that mainly included key industry participants, subject-matter experts (SMEs), C & D level executives of key market players, and independent industry consultants, among others; to obtain and verify critical qualitative and quantitative information as well as to assess future market prospects of the varicose vein treatment industry.

The secondary sources referred to for this research study include corporate filings (such as annual reports, SEC filings, investor presentations, and financial statements); research journals; press releases; as well as articles published by various trade, business, and professional associations.

Get Free Brochure: https://www.marketsandmarkets.com/pdfdownload.asp?id=22524107

As of 2015, Medtronic plc (Ireland), AngioDynamics, Inc. (U.S.), and biolitec AG (Austria) are some of the key players of the varicose vein treatment market in North America and Europe. Major market players were witnessed to adopt organic as well as (new product launches) as well as inorganic growth strategies (acquisitions and agreements) to enhance their market shares and positions during 2013-2016; with new product launch being the most-prominent growth strategy adopted by majority of market players. Several market players also pursued the strategy of strategic acquisitions to strengthen their market positions and enhance their R&D capabilities.

Contact:
Mr. Shelly Singh
North - Dominion Plaza,
17304,Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: [email protected]